Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |